391 results on '"Pfaender, Stephanie"'
Search Results
2. Host determinants and responses underlying SARS-CoV-2 liver tropism
3. Olfactory receptors impact pathophysiological processes of lung diseases in bronchial epithelial cells
4. Fading SARS-CoV-2 humoral VOC cross-reactivity and sustained cellular immunity in convalescent children and adolescents
5. Copper and silver thin film systems display differences in antiviral and antibacterial properties -- implications for the prevention of SARS-CoV-2 infections
6. Attitude towards and perception of individual safety after SARS-CoV-2 vaccination among German cancer patients
7. Impact of low eGFR on the immune response against COVID-19
8. Exploring the relationship between HCMV serostatus and outcomes in COVID-19 sepsis
9. SARS-CoV-2 infects human cardiomyocytes promoted by inflammation and oxidative stress
10. Inhibitors of dihydroorotate dehydrogenase cooperate with molnupiravir and N4-hydroxycytidine to suppress SARS-CoV-2 replication
11. Establishment of well-differentiated camelid airway cultures to study Middle East respiratory syndrome coronavirus
12. Nanoscale copper and silver thin film systems display differences in antiviral and antibacterial properties
13. The triglyceride-synthesizing enzyme diacylglycerol acyltransferase 2 modulates the formation of the hepatitis C virus replication organelle.
14. A realistic transfer method reveals low risk of SARS-CoV-2 transmission via contaminated euro coins and banknotes
15. Detection of pre-existing SARS-CoV-2-reactive T cells in unexposed renal transplant patients
16. Robust T Cell Response Toward Spike, Membrane, and Nucleocapsid SARS-CoV-2 Proteins Is Not Associated with Recovery in Critical COVID-19 Patients
17. Productive infection of primary human hepatocytes with SARS-CoV-2 induces antiviral and proinflammatory responses
18. Natural and hybrid immunity after SARS-CoV-2 infection in children and adolescents
19. LY6E impairs coronavirus fusion and confers immune control of viral disease
20. Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 by WHO-Recommended Hand Rub Formulations and Alcohols
21. Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform
22. The Magnitude and Functionality of SARS-CoV-2 Reactive Cellular and Humoral Immunity in Transplant Population Is Similar to the General Population Despite Immunosuppression
23. Immune protection against reinfection with nonprimate hepacivirus
24. Virucidal Activity of World Health Organization–Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging Coronaviruses
25. Frequent occurrence of nonprimate hepacivirus infections in Thoroughbred breeding horses – A cross-sectional study for the occurrence of infections and potential risk factors
26. Increased SARS‐CoV‐2 reactive low avidity T cells producing inflammatory cytokines in pediatric post‐acute COVID‐19 sequelae (PASC).
27. Significant Fade of Neutralizing Antibodies and Stable Cellular Immunity in 4 Times COVID-19 Vaccinated Noninfected Compared to COVID-19 Convalescent and 3 Times Vaccinated Hemodialysis Patients
28. Relevance of microRNAs in SARS-CoV-2 infection of primary human hepatocytes
29. SARS-CoV-2 vaccination improves HBV seroconversion rate through heterological immunity
30. Immunogenicity of Bivalent Omicron BA.4/5–Adapted Vaccine in Hemodialysis Patients
31. Frequent presence of hepaci and pegiviruses in commercial equine serum pools
32. Low avidity circulating SARS-CoV-2 reactive CD8+ T cells with proinflammatory TEMRA phenotype are associated with post-acute sequelae of COVID-19
33. Increased migratory/activated CD8+ T cell and low avidity SARS-CoV-2 reactive cellular response in post-acute COVID-19 syndrome
34. Impact of SARS-CoV-2 vaccination on systemic immune responses in people living with HIV
35. Superior humoral immunity in vaccinated SARS-CoV-2 convalescence as compared to SARS-COV-2 infection or vaccination
36. Comparison of disease-modifying anti-rheumatic drugs in inducing immunogenicity to SARS-CoV2 vaccines in adult patients with autoimmune musculoskeletal inflammatory rheumatic diseases
37. SARS-CoV-2 neutralizing camelid heavy-chain-only antibodies as powerful tools for diagnostic and therapeutic applications
38. Characterization of a robot-assisted UV-C disinfection for the inactivation of surface-associated microorganisms and viruses
39. Different humoral but similar cellular responses of patients with autoimmune inflammatory rheumatic diseases under disease-modifying antirheumatic drugs after COVID-19 vaccination
40. Immune response in ofatumumab treated multiple sclerosis patients after SARS-CoV-2 vaccination
41. SARS-CoV-2 entry route impacts a range of downstream viral and cellular processes
42. Vaccine-associated enhanced respiratory pathology in COVID-19 hamsters after TH2-biased immunization
43. Conserved requirement of autophagy-related effectors during coronavirus replication
44. Impact of low eGFR on the immune response against COVID-19
45. Interdisziplinäre Perspektiven zur Bedeutung der Aerosolübertragung für das Infektionsgeschehen von SARS-CoV-2
46. Mouthrinses against SARS-CoV-2 – High antiviral effectivity by membrane disruption in vitro translates to mild effects in a randomized placebo-controlled clinical trial
47. Inferior cellular and humoral immunity against Omicron and Delta variants of concern compared with SARS-CoV-2 wild type in hemodialysis patients immunized with 4 SARS-CoV-2 vaccine doses
48. Pentagalloylglucose, a highly bioavailable polyphenolic compound present in Cortex moutan, efficiently blocks hepatitis C virus entry
49. Inactivation of Hepatitis C Virus Infectivity by Human Breast Milk
50. Editorial overview: Coronaviruses 2024
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.